Therefore, more investigations are needed on how specific bacteria or their products can stimulate the cGAS-STING pathway and enhance the anti-tumor immune response, which may promote the development of novel therapeutic strategies or interventions for CRC treatment. Here, CGAS is linked to neoplasm.